David Martínez-Cuadrón (David Martinez-Cuadron)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 38

Top Topics

Acute Myeloid Leukemia

Systematic Review

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

Expert review of clinical pharmacology

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Solana-Altabella, Rebeca Rodriguez-Veiga, David Martínez-Cuadrón, Pau Montesinos
A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold? Annals of hematology (2024)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, David Martínez-Cuadrón, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, Irene Navarro-Vicente, David Martínez-Campuzano, Raquel García-Ruiz, Pilar Lloret, Pedro Asensi, Ana Osa-Sáez, Jaume Aguero, María Rodríguez-Serrano, Francisco Buendía-Fuentes, Juan Eduardo Megías-Vericat, Beatriz Martín-Herreros, Eva Barragán, Claudia Sargas, Maribel Salas, Margaret Wooddell, Charles Dharmani, Miguel Angel Sanz, Javier de la Rubia, Pau Montesinos
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15 (8) (2023)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia. Expert opinion on emerging drugs 27 (1) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Blanca Boluda, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Laura Torres-Miñana, Claudia Sargas, Miguel Angel Sanz, Carmela Borrell-García, Eduardo López-Briz, José Luis Poveda-Andrés, Javier de la Rubia, Pau Montesinos, David Martínez-Cuadrón
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers 14 (8) (2022)
Emilie Bérard, Christoph Röllig, Sarah Bertoli, Arnaud Pigneux, Suzanne Tavitian, Michael Kramer, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Müller-Tidow, Claudia Dorothea Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez Arbolí, Cristina Gil, Juan Bergua, Teresa Bernal, Adolfo de la Fuente Burguera, Eric Delabesse, Audrey Bidet, Pierre-Yves Dumas, Pau Montesinos, Christian Recher
A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries. Blood cancer journal 12 (7) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Jorge Labrador-Gomez, David Martínez-Cuadrón, Adolfo de la Fuente, Rebeca Rodríguez-Veiga, Josefina Serrano, Mar Tormo, Eduardo Rodriguez-Arboli, Fernando Ramos, Teresa Bernal, María López-Pavía, Fernanda Trigo, María Pilar Martínez-Sánchez, Juan-Ignacio Rodríguez-Gutiérrez, Carlos Rodríguez-Medina, Cristina Gil, Daniel García Belmonte, Susana Vives, Maria Angeles Foncillas, Manuel Mateo Pérez Encinas, Andrés Novo, Isabel Recio, Gabriela Rodríguez-Macías, Juan Miguel Bergua, Víctor Noriega, Esperanza Lavilla-Rubira, Alicia Roldán Pérez, Miguel Angel Sanz, Pau Montesinos, null On Behalf Of Pethema Group
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry. Cancers 14 (9) (2022)
Jorge Labrador-Gomez, Miriam Saiz-Rodriguez, Dunia de Miguel, Almudena de Laiglesia, Carlos Rodríguez-Medina, María Belén Vidriales, Manuel Pérez-Encinas, María José Sánchez-Sánchez, Rebeca Cuello, Alicia Roldán Pérez, Susana Vives, Gonzalo Benzo-Callejo, Mercedes Colorado, María García-Fortes, María José Sayas, Carmen Olivier, Isabel Recio, Diego Conde-Royo, Álvaro Bienert-García, María Vahi, Carmen Muñoz-García, Cristina Seri-Merino, María Del Mar Tormo Díaz, Ferran Vall-Llovera, Maria Angeles Foncillas, David Martínez-Cuadrón, Miguel Angel Sanz, Pau Montesinos
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience. Cancers 14 (7) (2022)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, José Luis Poveda-Andrés, Pau Montesinos
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. Pharmaceutics 14 (4) (2022)
David Martínez-Cuadrón, Josefina Serrano, José Mário Mariz, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Raimundo García-Boyero, Carlos Rodríguez-Medina, Carmen Martínez-Chamorro, Marta Polo, Juan Bergua, Eliana Aguiar, María L Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Ana Espadana, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Graça Vasconcelos, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, María C Chillón, Juan I Rodríguez-Gutiérrez, María-José Calasanz, Jorge Labrador-Gomez, Juan A López, Blanca Boluda, Rebeca Rodríguez-Veiga, Joaquin Martinez Lopez, Eva Barragán, Miguel Angel Sanz, Pau Montesinos, null On Behalf Of The Pethema Group
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia. Cancers 14 (11) (2022)
Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas, Alejandro Sanz, Lorenzo Algarra, Pilar Herrera-Puente, Raimundo García-Boyero, Manuel Barrios, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Josefina Serrano-López, Joaquin Martinez Lopez, María José Sayas-Lloris, María Teresa Olave, Rosalía Riaza-Grau, Teresa Bernal-Del Castillo, María José Larráyoz, Raquel Amigo, Antonio Jiménez-Velasco, Joaquín Sánchez, Rosa María Ayala, Carlos Blas López, Daniel Lainez-González, Juana Serrano-López, Miguel Angel Sanz, Juan Manuel Alonso-Domínguez, Pau Montesinos
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. Disease markers 2022 (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Rosa María Ayala, Inmaculada Rapado, Esther Onecha, David Martínez-Cuadrón, Gonzalo Carreno-Tarragona, Juan Miguel Bergua, Susana Vives, Jesus Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla-Rubira, Cristina Gil, Jose Luis López Lorenzo, María Belén Vidriales, Jorge Labrador-Gomez, José Francisco Falantes, María José Sayas, Juan José Lahuerta, Eva Barragán, Felipe Prosper, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos, null On Behalf Of The Programa Para El Estudio de la Terapeutica En Hemopatias Malignas Pethema Cooperative Study Group
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial. Cancers 13 (10) (2021)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Ines Gómez, Pilar Solves, Ignacio Lorenzo, Jose Luis Piñana, Jaime Sanz, Manuel Guerreiro, Juan Montoro Gómez, Alvaro Díaz-González, Javier Marco, Albert Blanco, Miguel Angel Sanz, Pau Montesinos
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain. Journal of clinical apheresis 36 (4) (2021)
David Martínez-Cuadrón, Juan Eduardo Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan-Miguel Bergua, Jose L Lopez-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavia, Mar Tormo, Jesus Lorenzo Algarra, Maria Luz Amigo, Maria Jose Sayas, Jorge Labrador, Juan I Rodríguez-Gutiérrez, Celina Benavente Cuesta, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García Belmonte, María Mar Herráez-Albendea, Graça V Esteves, María Isabel Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mário Mariz, Blanca Boluda, Miguel A Sanz, Pau Montesinos
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study. Blood advances (2021)
Juan José Lahuerta, Maria Vidriales Vicente, Amparo Sempere, Fabián Tarín, Enrique Colado, Celina Benavente, María-Teresa Cedena, Joaquín Sánchez, Teresa Caballero-Velazquez, Lourdes Cordon, Juan-José Garcés, Catia Simoes, David Martínez-Cuadrón, Teresa Bernal Del Castillo, Carmen Botella, Sofia Grille, Josefina Serrano, Carlos Rodríguez-Medina, Lorenzo Algarra, Juan Manuel Alonso-Domínguez, María-Luz Amigo, Manuel Barrios, Raimundo García-Boyero, Mercedes Colorado, Jaime Pérez-Oteyza, Manuel Mateo Pérez Encinas, Lisette Costilla-Barriga, María-José Sayas, Olga Pérez, Marcos González-Díaz, José A Pérez-Simón, Joaquin Martinez Lopez, Claudia Sossa, Alberto Orfao, Jesús F San Miguel, Miguel Angel Sanz, Pau Montesinos, null null
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia. Leukemia 35 (8) (2021)
María P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, Susana Vives, Juan Miguel Bergua, Anna Torrent, Sara Suárez-Varela, Blanca Boluda, Joaquín Martínez-López, Isabel Cano-Ferri, Evelyn Acuña-Cruz, Laura Torres-Miñana, Beatriz Martín-Herreros, Alfons Serrano, Amparo Sempere, Eva Barragán, Claudia Sargas, Miguel Sanz, David Martínez-Cuadrón, Pau Montesinos, null null
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Annals of hematology 100 (6) (2021)
Christian Recher, Christoph Röllig, Emilie Bérard, Sarah Bertoli, Pierre-Yves Dumas, Suzanne Tavitian, Michael Kramer, Hubert Serve, Martin Bornhäuser, Uwe Platzbecker, Carsten Muller-Tidow, Claudia D Baldus, David Martínez-Cuadrón, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez Arbolí, Cristina Gil, Juan Bergua, Teresa Bernal, Adolfo de la Fuente Burguera, Eric Delabesse, Audrey Bidet, Arnaud Pigneux, Pau Montesinos
Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries. Leukemia (2021)
Miriam Saiz-Rodriguez, Jorge Labrador-Gomez, Beatriz Cuevas, David Martínez-Cuadrón, Verónica Campuzano, Raquel Alcaraz, Isabel Cano, Miguel Angel Sanz, Pau Montesinos
Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis. Cancers 13 (22) (2021)
Blanca Boluda, David Martínez-Cuadrón, Lorenzo Algarra, Isabel Cano, María J Sayas, Evelyn Acuña-Cruz, Albert Blanco, Javier Marco-Ayala, Rosalía DeLapuerta, Álvaro Díaz-González, María Del Mar Tormo Díaz, Rebeca Rodriguez-Veiga, Raimundo García, José Luis Piñana, María López-Pavía, Eva Barragán, María L Amigo, Claudia Sargas, Aurelio López, Antonio Solana-Altabella, Cristina Gil, Juan Eduardo Megías-Vericat, Miguel Angel Sanz, Pau Montesinos
Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leukemia & lymphoma 62 (11) (2021)
Octavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation. Future oncology (London, England) 17 (2) (2020)
David Martínez-Cuadrón, Gabriela Rodríguez-Macías, Rebeca Rodríguez-Veiga, Blanca Boluda, Pau Montesinos
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports. Clinical drug investigation 40 (3) (2020)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, María José Herrero, Rebeca Rodríguez-Veiga, Antonio Solana-Altabella, Blanca Boluda, Octavio Ballesta-López, Isabel Cano, Evelyn Acuña-Cruz, José Cervera, José Luis Poveda, Miguel Angel Sanz, Salvador F Aliño, Pau Montesinos
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma 62 (3) (2020)
David Martínez-Cuadrón, Josefina Serrano, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, José A Pérez-Simón, Raimundo García-Boyero, Carlos Rodríguez-Medina, María López-Pavía, Celina Benavente, Juan-Miguel Bergua, Esperanza Lavilla-Rubira, María-Luz Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Mercedes Colorado, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Gabriela Rodríguez-Macías, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, Fernando Ramos, Juan I Rodríguez-Gutiérrez, Lisette Costilla-Barriga, Jorge Labrador, Blanca Boluda, Rebeca Rodriguez-Veiga, Joaquin Martinez Lopez, Miguel Angel Sanz, Pau Montesinos
Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing? Leukemia 35 (6) (2020)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, Pau Montesinos
Precision medicine in acute myeloid leukemia: where are we now and what does the future hold? Expert review of hematology 13 (10) (2020)
Olga Salamero, David Martínez-Cuadrón, Marta Anna Sobas, Celina Benavente, Susana Vives, Javier de laSerna, Manuel Mateo Pérez Encinas, Lourdes Escoda, Cristina Gil, Salut Brunet, Fernando Ramos, Aleksandra Holowiecka, Mariluz Amigo, Isabel Krsnik, Félix Manso, Jesús Arias, José González-Campos, Josefina Serrano, Jalanta Oleksiuk, Manuel Barrios, Raimundo García-Boyero, Andrés Novo, Miguel Angel Sanz, Pau Montesinos, null null
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry. Leukemia & lymphoma 60 (11) (2019)